Developer docs
API playgroundTry for free, no card

Search company profiles

Edgewater Capital Partners

Full company profile

uuid0007iyv

Namestring
Edgewater Capital Partners
Legal namestring
Edgewater Capital Partners
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Edgewater Capital Partners is a Cleveland, Ohio-based private equity firm founded in 1998 that focuses exclusively on acquiring lower middle-market performance materials, components, and services businesses. The firm operates across four dedicated practice areas—Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals—and typically invests $3-7 million in equity per transaction in companies generating $20-100 million in annual revenue, with completed transactions ranging from $15 million to $150 million in revenue. Deal flow is sourced through deep sector relationships, an Operating Partner network spanning former industry executives, and a focus on owner-operator situations and corporate carve-outs.

The firm's current portfolio includes ten active companies spanning water purification (AmeriWater), crop nutrition (Deerpoint Group), engineered components (Evantic), pharmaceutical CDMO (GL Chemtec), defense composites (Iten Defense, pending sale to NP Aerospace), electronics manufacturing (Naprotek), specialty graphite (NeoGraf Solutions), protein analytics CRO (Prolytix), clinical research (REV Clinical), and oil and gas artificial lift (Well Master). The firm generates revenue through management fees on committed fund capital (Edgewater Capital Partners Fund IV closed at $330 million in December 2023) and performance-based carried interest on portfolio company exits, including notable realizations such as the Tractech sale to Eaton Corporation at a 105% net IRR and the pending divestiture of Luxium Solutions to Excelitas Technologies.

Edgewater differentiates through three pillars: deep sector experience (20+ years of dedicated thesis development), Midwestern Values emphasizing cultural fit in owner-operator transactions (representing nearly half of all deals), and a growth-enabling investment philosophy that emphasizes operational support beyond capital deployment. The firm maintains a lean team of 11-50 employees across managing partners, partners, principals, vice presidents, associates, and business development staff, augmented by an Operating Partner ecosystem with deep industry expertise in materials, life sciences, and aerospace/defense.

Short descriptiontext

Edgewater Capital Partners is a Cleveland-based private equity firm founded in 1998 that acquires lower middle-market performance materials, specialty industrials, life sciences, and specialty chemicals companies, typically investing $3-7M in equity per transaction.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCleveland, United States
HQ citystring
Cleveland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investing, lower middle market, performance materials, specialty chemicals, sector focused buyouts
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code2 codes
  • All Other Financial Investment Activities52399
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Private Equity Investment Management
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Private equity firms typically charge management fees on committed capital under management, generating steady revenue regardless of investment performance.

edgewatercapital.com
2Carried Interest
TypeTransaction Fee
Description

Performance-based carried interest from successful portfolio company exits, representing the primary upside for fund managers after returning capital to LPs.

edgewatercapital.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Edgewater Capital Partners is a sector-focused private equity firm that acquires and manages lower middle-market companies in performance materials, components, and services. The firm invests in companies generating $20-100 million in revenue, primarily through buyouts of owner-operator businesses and corporate carve-outs across Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals sectors, with typical equity investments of $3-7 million per deal in transactions ranging from $15-150 million in revenue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Accelerated diligence timelines due to deep sector expertise
+2 more records
Product overview1 text field

Edgewater Capital Partners operates as a sector-focused private equity firm managing a portfolio of 10 current portfolio companies across performance materials and services sectors. The portfolio includes AmeriWater (healthcare water purification), Deerpoint Group (crop nutrition), Evantic (engineered components under Altamira, PFI, Vertec brands), GL Chemtec (pharmaceutical CDMO), Iten Defense (composites and armor), Naprotek (electronics manufacturing), NeoGraf Solutions (graphite products), Prolytix (analytical CRO), REV Clinical (clinical research), and Well Master (artificial lift products). The firm also has 20+ realized investments including Luxium Solutions, Pure Wafer, Callery, and others. This is a platform of independent portfolio companies rather than a unified product architecture.

Product and service11 records
1AmeriWater
CategoryPortfolio Company - Healthcare Water Purification
Description

Portfolio company and industry leader in the design, manufacture, installation, and supply of water purification systems and services for the healthcare sector (dialysis, sterile processing) and industrial applications.

2Deerpoint Group
CategoryPortfolio Company - Crop Nutrition
Description

Portfolio company that manufactures and develops innovative crop nutrition products for irrigated agriculture and chemical solutions to treat irrigation water, delivering fertigation services and water treatment programs.

3Evantic
CategoryPortfolio Company - Engineered Components
Description

Portfolio company manufacturing high-performance engineered components for the semiconductor, aerospace, energy, and industrial sectors, offering machined components, molded shapes, tapes, and specialty components through the Altamira, PFI, and Vertec brands.

4GL Chemtec
CategoryPortfolio Company - Pharmaceutical CDMO
Description

Portfolio company and North American Specialty CDMO providing advanced chemistry services to pharmaceutical, biotech, and medical device sectors, specializing in advanced multi-step organic synthesis, process R&D, and scale-up for API development.

5Iten Defense
CategoryPortfolio Company - Defense Composites
Description

Portfolio company and leading provider of advanced composites and armor solutions for personal protective equipment, fixed and rotary-wing aircraft, tactical vehicles, and maritime vessels with specialized ballistic armor expertise.

6Naprotek
CategoryPortfolio Company - Electronics Manufacturing
Description

Portfolio company and electronic manufacturing services provider of quick turn PCBA, design for manufacturability, system integration, and testing services for high-reliability applications.

7NeoGraf Solutions
CategoryPortfolio Company - Specialty Graphite
Description

Portfolio company and industry-leading designer, formulator, and manufacturer of specialty natural graphite products for EV, graphene, alternative energy, electronic thermal management, industrial seals, petrochemical, nuclear, building and construction, and flame retardancy sectors.

8Prolytix
CategoryPortfolio Company - Analytical CRO
Description

Portfolio company and leading analytical CRO with 30+ years of protein chemistry experience in plasma-based protein therapies, monoclonal and polyclonal antibodies, recombinant proteins, cell and gene therapies, and vaccines from discovery through commercial GMP release.

9REV Clinical
CategoryPortfolio Company - Clinical CRO
Description

Portfolio company and multi-national clinical contract research organization with deep experience in designing and managing clinical trials across oncology, neurology, ophthalmology, and rare diseases, providing end-to-end Phase I-IV clinical trial services.

10Well Master
CategoryPortfolio Company - Oil & Gas Artificial Lift
Description

Portfolio company and leader in artificial lift marketplace, specializing in engineering, manufacturing, and distribution of durable, high-performance artificial lift products and solutions to optimize oil and gas production and extend well life.

11Edgewater Capital Partners Fund IV
CategoryPrivate Equity Fund
Description

Private equity fund vehicle providing committed capital for sector-focused investments in lower middle-market performance materials, components, and services businesses across four sectors: Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals. The fund charges management fees on committed capital and earns carried interest from successful portfolio exits.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeOthers
Description

Legal counsel to SK Capital in the acquisition of Saint-Gobain's crystals business.

Strategic tierMinorTypeOthers
Description

Legal counsel to Edgewater Capital Partners in multiple transactions including the Luxium Solutions acquisition and various portfolio company investments.

Strategic tierMinorTypeOthers
Description

Exclusive financial advisor to AmeriWater in its acquisition by Edgewater Capital Partners.

Strategic tierMinorTypeOthers
Description

Debt financing provider for the Luxium Solutions acquisition transaction.

Strategic tierMinorTypeOthers
Description

Debt financing provider for Edgewater's acquisition of NeoGraf Solutions.

Strategic tierMinorTypeOthers
Description

Debt financing provider for Edgewater's acquisition of NeoGraf Solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lower middle-market PE firm focused on industrial, manufacturing, and specialty businesses. Comparable deal-size range and similar portfolio construction philosophy (operational value-creation in industrial niches).

TypeDirect peer
Description

Detroit-based lower middle-market private equity firm with strong industrial and specialty manufacturing focus. Geographically and operationally adjacent to Edgewater (both Midwest-rooted, similar deal-size range, similar portfolio construction philosophy).

TypeBroad incumbent
Description

Established industrial-focused private equity firm managing multiple billion-dollar funds. AIP operates in many of Edgewater's target sectors (specialty industrials, aerospace/defense, advanced materials) at a meaningfully larger scale.

TypeDirect peer
Description

Specialty materials, chemicals, and life sciences focused private equity firm. SK Capital and Edgewater have a demonstrated co-investment history (Luxium Solutions), and both target the same sectors and lower middle-market opportunities, making them the closest comparable peer.

TypeDirect peer
Description

Lower middle-market private equity firm focused on industrial, aerospace/defense, and specialty manufacturing. Similar deal-size profile and sector overlap make Insight Equity a closely comparable peer to Edgewater in specialty industrials.

TypeDirect peer
Description

Sector-focused private equity firm investing in healthcare, industrial, and specialty chemicals/materials businesses in the lower middle market. Arsenal's vertical specialization and fund-size profile ($1B+ funds) closely mirror Edgewater's investment approach with somewhat larger scale.

TypeBroad incumbent
Description

Global lower middle-market private equity firm with broad sector coverage including industrials, healthcare, and consumer. Riverside's scale and breadth make it a broad incumbent peer rather than a direct specialist competitor.

TypeDirect peer
Description

Lower middle-market industrial and specialty chemicals PE firm. Aterian previously owned NeoGraf Solutions before Edgewater acquired it in 2023, illustrating direct competition for the same assets and overlap in sector focus.

TypeBroad incumbent
Description

Large global lower middle-market PE firm with multiple sector-focused funds including industrials, chemicals, and life sciences. H.I.G.'s broader scale and broader sector mandate make it a broad incumbent peer; Jason Burmer (Edgewater's BD Principal) previously worked at H.I.G.

TypeBroad incumbent
Description

Large private equity firm with significant industrial, manufacturing, and specialty chemicals exposure. While Platinum operates at materially larger scale, its industrial-sector mandate overlaps meaningfully with Edgewater's specialty industrials practice.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A13 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Edgewater Capital Partners

Private Equity Investment Managementedgewatercapital.com

Edgewater Capital Partners is a Cleveland-based private equity firm founded in 1998 that acquires lower middle-market performance materials, specialty industrials, life sciences, and specialty chemicals companies, typically investing $3-7M in equity per transaction.

What Edgewater Capital Partners does

Edgewater Capital Partners is a Cleveland, Ohio-based private equity firm founded in 1998 that focuses exclusively on acquiring lower middle-market performance materials, components, and services businesses. The firm operates across four dedicated practice areas—Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals—and typically invests $3-7 million in equity per transaction in companies generating $20-100 million in annual revenue, with completed transactions ranging from $15 million to $150 million in revenue. Deal flow is sourced through deep sector relationships, an Operating Partner network spanning former industry executives, and a focus on owner-operator situations and corporate carve-outs.

The firm's current portfolio includes ten active companies spanning water purification (AmeriWater), crop nutrition (Deerpoint Group), engineered components (Evantic), pharmaceutical CDMO (GL Chemtec), defense composites (Iten Defense, pending sale to NP Aerospace), electronics manufacturing (Naprotek), specialty graphite (NeoGraf Solutions), protein analytics CRO (Prolytix), clinical research (REV Clinical), and oil and gas artificial lift (Well Master). The firm generates revenue through management fees on committed fund capital (Edgewater Capital Partners Fund IV closed at $330 million in December 2023) and performance-based carried interest on portfolio company exits, including notable realizations such as the Tractech sale to Eaton Corporation at a 105% net IRR and the pending divestiture of Luxium Solutions to Excelitas Technologies.

Edgewater differentiates through three pillars: deep sector experience (20+ years of dedicated thesis development), Midwestern Values emphasizing cultural fit in owner-operator transactions (representing nearly half of all deals), and a growth-enabling investment philosophy that emphasizes operational support beyond capital deployment. The firm maintains a lean team of 11-50 employees across managing partners, partners, principals, vice presidents, associates, and business development staff, augmented by an Operating Partner ecosystem with deep industry expertise in materials, life sciences, and aerospace/defense.

Edgewater Capital Partners firmographics

Firmographics
Name
Edgewater Capital Partners
Legal name
Edgewater Capital Partners
Website
https://edgewatercapital.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Edgewater Capital Partners is a Cleveland-based private equity firm founded in 1998 that acquires lower middle-market performance materials, specialty industrials, life sciences, and specialty chemicals companies, typically investing $3-7M in equity per transaction.
Ownership category
akta.pro rank

Edgewater Capital Partners industry classification

Industry
Product category
Private Equity Investment Management
NAICS
All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Private equity investing
  • Lower middle market
  • Performance materials
  • Specialty chemicals
  • Sector focused buyouts

Where Edgewater Capital Partners is headquartered

Location

Headquarters

HQ city
Cleveland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Edgewater Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Management Fees: Private equity firms typically charge management fees on committed capital under management, generating steady revenue regardless of investment performance.
  2. Carried Interest: Performance-based carried interest from successful portfolio company exits, representing the primary upside for fund managers after returning capital to LPs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Edgewater Capital Partners product offering

Product offering

Core offering

Edgewater Capital Partners is a sector-focused private equity firm that acquires and manages lower middle-market companies in performance materials, components, and services. The firm invests in companies generating $20-100 million in revenue, primarily through buyouts of owner-operator businesses and corporate carve-outs across Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals sectors, with typical equity investments of $3-7 million per deal in transactions ranging from $15-150 million in revenue.

Product overview

Edgewater Capital Partners operates as a sector-focused private equity firm managing a portfolio of 10 current portfolio companies across performance materials and services sectors. The portfolio includes AmeriWater (healthcare water purification), Deerpoint Group (crop nutrition), Evantic (engineered components under Altamira, PFI, Vertec brands), GL Chemtec (pharmaceutical CDMO), Iten Defense (composites and armor), Naprotek (electronics manufacturing), NeoGraf Solutions (graphite products), Prolytix (analytical CRO), REV Clinical (clinical research), and Well Master (artificial lift products). The firm also has 20+ realized investments including Luxium Solutions, Pure Wafer, Callery, and others. This is a platform of independent portfolio companies rather than a unified product architecture.

Differentiator

Problem solved

Functional benefit

Products and services

  • AmeriWater Portfolio company and industry leader in the design, manufacture, installation, and supply of water purification systems and services for the healthcare sector (dialysis, sterile processing) and industrial applications.
  • Deerpoint Group Portfolio company that manufactures and develops innovative crop nutrition products for irrigated agriculture and chemical solutions to treat irrigation water, delivering fertigation services and water treatment programs.
  • Evantic Portfolio company manufacturing high-performance engineered components for the semiconductor, aerospace, energy, and industrial sectors, offering machined components, molded shapes, tapes, and specialty components through the Altamira, PFI, and Vertec brands.
  • GL Chemtec Portfolio company and North American Specialty CDMO providing advanced chemistry services to pharmaceutical, biotech, and medical device sectors, specializing in advanced multi-step organic synthesis, process R&D, and scale-up for API development.
  • Iten Defense Portfolio company and leading provider of advanced composites and armor solutions for personal protective equipment, fixed and rotary-wing aircraft, tactical vehicles, and maritime vessels with specialized ballistic armor expertise.
  • Naprotek Portfolio company and electronic manufacturing services provider of quick turn PCBA, design for manufacturability, system integration, and testing services for high-reliability applications.
  • NeoGraf Solutions Portfolio company and industry-leading designer, formulator, and manufacturer of specialty natural graphite products for EV, graphene, alternative energy, electronic thermal management, industrial seals, petrochemical, nuclear, building and construction, and flame retardancy sectors.
  • Prolytix Portfolio company and leading analytical CRO with 30+ years of protein chemistry experience in plasma-based protein therapies, monoclonal and polyclonal antibodies, recombinant proteins, cell and gene therapies, and vaccines from discovery through commercial GMP release.
  • REV Clinical Portfolio company and multi-national clinical contract research organization with deep experience in designing and managing clinical trials across oncology, neurology, ophthalmology, and rare diseases, providing end-to-end Phase I-IV clinical trial services.
  • Well Master Portfolio company and leader in artificial lift marketplace, specializing in engineering, manufacturing, and distribution of durable, high-performance artificial lift products and solutions to optimize oil and gas production and extend well life.
  • Edgewater Capital Partners Fund IV Private equity fund vehicle providing committed capital for sector-focused investments in lower middle-market performance materials, components, and services businesses across four sectors: Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals. The fund charges management fees on committed capital and earns carried interest from successful portfolio exits.

Quantifiable outcome

  • Accelerated diligence timelines due to deep sector expertise
  • +2 more outcomes

Companies that use Edgewater Capital Partners

Customer profile

Segments5 records

Ideal customer profiles2 records

Edgewater Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Edgewater Capital Partners partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor.

  • Latham & Watkins LLPminorOthersLegal counsel to SK Capital in the acquisition of Saint-Gobain's crystals business.
  • Taft Stettinius & Hollister LLPminorOthersLegal counsel to Edgewater Capital Partners in multiple transactions including the Luxium Solutions acquisition and various portfolio company investments.
  • Lincoln InternationalminorOthersExclusive financial advisor to AmeriWater in its acquisition by Edgewater Capital Partners.
  • KeyBanc Capital MarketsminorOthersDebt financing provider for the Luxium Solutions acquisition transaction.
  • Gladstone Capital CorporationminorOthersDebt financing provider for Edgewater's acquisition of NeoGraf Solutions.
  • Greyrock Capital GroupminorOthersDebt financing provider for Edgewater's acquisition of NeoGraf Solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Edgewater Capital Partners competitors and assessment

Company assessment

Direct peers

  • Wynnchurch Capital: Lower middle-market PE firm focused on industrial, manufacturing, and specialty businesses. Comparable deal-size range and similar portfolio construction philosophy (operational value-creation in industrial niches).
  • Huron Capital: Detroit-based lower middle-market private equity firm with strong industrial and specialty manufacturing focus. Geographically and operationally adjacent to Edgewater (both Midwest-rooted, similar deal-size range, similar portfolio construction philosophy).
  • SK Capital Partners: Specialty materials, chemicals, and life sciences focused private equity firm. SK Capital and Edgewater have a demonstrated co-investment history (Luxium Solutions), and both target the same sectors and lower middle-market opportunities, making them the closest comparable peer.
  • Insight Equity: Lower middle-market private equity firm focused on industrial, aerospace/defense, and specialty manufacturing. Similar deal-size profile and sector overlap make Insight Equity a closely comparable peer to Edgewater in specialty industrials.
  • Arsenal Capital Partners: Sector-focused private equity firm investing in healthcare, industrial, and specialty chemicals/materials businesses in the lower middle market. Arsenal's vertical specialization and fund-size profile ($1B+ funds) closely mirror Edgewater's investment approach with somewhat larger scale.
  • Aterian Investment Partners: Lower middle-market industrial and specialty chemicals PE firm. Aterian previously owned NeoGraf Solutions before Edgewater acquired it in 2023, illustrating direct competition for the same assets and overlap in sector focus.

Broad incumbents

  • American Industrial Partners: Established industrial-focused private equity firm managing multiple billion-dollar funds. AIP operates in many of Edgewater's target sectors (specialty industrials, aerospace/defense, advanced materials) at a meaningfully larger scale.
  • The Riverside Company: Global lower middle-market private equity firm with broad sector coverage including industrials, healthcare, and consumer. Riverside's scale and breadth make it a broad incumbent peer rather than a direct specialist competitor.
  • H.I.G. Capital: Large global lower middle-market PE firm with multiple sector-focused funds including industrials, chemicals, and life sciences. H.I.G.'s broader scale and broader sector mandate make it a broad incumbent peer; Jason Burmer (Edgewater's BD Principal) previously worked at H.I.G.
  • Platinum Equity: Large private equity firm with significant industrial, manufacturing, and specialty chemicals exposure. While Platinum operates at materially larger scale, its industrial-sector mandate overlaps meaningfully with Edgewater's specialty industrials practice.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Edgewater Capital Partners social profiles

Digital presence

Edgewater Capital Partners compliance and trust

Trust signal

Compliance3 records

Edgewater Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Edgewater Capital Partners leadership team

Management profile

Number of profiles

Profiles14 records

Edgewater Capital Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Edgewater Capital Partners M&A and investment

M&A and investment

M&A13 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edgewater Capital Partners

What does Edgewater Capital Partners do?

Edgewater Capital Partners is a sector-focused private equity firm that acquires and manages lower middle-market companies in performance materials, components, and services. The firm invests in companies generating $20-100 million in revenue, primarily through buyouts of owner-operator businesses and corporate carve-outs across Specialty Industrials, Life Sciences, Advanced Materials, and Specialty Chemicals sectors, with typical equity investments of $3-7 million per deal in transactions ranging from $15-150 million in revenue.

Is Edgewater Capital Partners a public or private company?

Edgewater Capital Partners is a private company. It is classified as management employee owned and is currently operating.

When was Edgewater Capital Partners founded?

Edgewater Capital Partners was founded in 1998. It employs 1 to 10 people.

Where is Edgewater Capital Partners based?

Edgewater Capital Partners is headquartered in Cleveland, United States, in the North America region.

How does Edgewater Capital Partners make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are Edgewater Capital Partners's main competitors?

Direct peers on record are Wynnchurch Capital, Huron Capital, SK Capital Partners, Insight Equity, Arsenal Capital Partners and Aterian Investment Partners. Broad incumbents are American Industrial Partners, The Riverside Company, H.I.G. Capital and Platinum Equity.

Does Edgewater Capital Partners have an API?

No public API is recorded for Edgewater Capital Partners.

What industry is Edgewater Capital Partners in?

Edgewater Capital Partners's product category is Private Equity Investment Management. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The UKDefence manufacturer expands into US market with acquisitionCoventry-headquartered defence manufacturer NP Aerospace has signed a definitive agreement to acquire Ohio-based Iten Defense from private equity firm Edgewater Capital Partners and other minority shareholders, expanding its presence in the North American market. The acquisition will strengthen the combined group's portfolio of survivability and protection technologies, enhancing its ability to support defence and security customers with mission-critical armour solutions globally. The transaction remains subject to customary regulatory approvals and closing conditions.LinkedInCDMO industry outlook: insights from Edgewater Capital PartnersEdgewater Capital Partners advisor Brian Scanlan discussed the CDMO industry's outlook in a two-part podcast series, highlighting constrained funding and shifting demand as the sector approaches the end of 2025. The analysis emphasizes a strategic shift toward specialization over scale, with niche providers in radiopharma and peptides gaining traction amid global supply chain reshoring efforts.SK CapitalSK Capital Partners and Edgewater Capital Partners Announce Agreement to Sell Luxium Solutions to Excelitas TechnologiesAffiliates of SK Capital Partners and Edgewater Capital Partners have entered into an agreement to sell Luxium Solutions to Excelitas Technologies Corp., with the transaction expected to close in the coming months pending customary closing conditions and regulatory approvals. Since acquiring Luxium from Saint-Gobain in December 2022, the two private equity firms transformed the business through operational initiatives and the acquisitions of PLX, Inc. and Inrad Optics in 2024, expanding its capabilities in high precision optics and radiation detection. The strategic combination will strengthen Excelitas' technological capabilities and product portfolio while advancing Luxium's mission to deliver high-performance detection, imaging, and photonic solutions globally.Lincoln International LLCEdgewater Capital Partners has sold Fiber Materials Inc. to Spirit AeroSystemsEdgewater Capital Partners has sold Fiber Materials Inc. to Spirit AeroSystems. Fiber Materials Inc. specializes in high temperature composite materials for aerospace and defense applications, and Lincoln International served as the exclusive financial advisor for the transaction. The sale highlights the strategic interest in high-performance materials for mission-critical sectors.PR NewswireEdgewater Capital Partners Welcomes Joel Rathbun as PartnerEdgewater Capital Partners announced Joel Rathbun's appointment as Partner, focusing on business development, deal execution, and portfolio management. Rathbun brings over 26 years of experience, including leadership at Avient Corporation and Moelis & Company, with a background in advanced materials and specialty industrials.PR NewswireAmeriWater, a Portfolio Company of Edgewater Capital Partners, Appoints Doug Lohse as Chief Executive OfficerAmeriWater appointed Doug Lohse as CEO, succeeding Dennis Mahoney, who remains on the board. Lohse brings 25 years of leadership experience, including CEO of Avidity Science, which exited to ATS Corporation in November 2023. The appointment aims to drive AmeriWater's next phase of expansion and innovation.Business Wire BlogSK Capital Partners and Edgewater Capital Partners Announce Agreement to Sell Luxium Solutions to Excelitas TechnologiesSK Capital Partners and Edgewater Capital Partners have agreed to sell Luxium Solutions to Excelitas Technologies Corp., with the transaction expected to close in the coming months pending regulatory approvals. Luxium, which was carved out from Saint-Gobain in 2022 and subsequently acquired by the two private equity firms, has since expanded through acquisitions of PLX, Inc. and Inrad Optics in 2024. The strategic combination is intended to strengthen Excelitas' technological capabilities and product portfolio while advancing Luxium's mission to deliver high-performance detection, imaging, and photonic solutions globally.CriticalpointCriticalPoint Advises PLX, Inc. on its Sale to Luxium Solutions, a portfolio company of SK Capital Partners and Edgewater Capital PartnersCriticalPoint advised PLX, Inc. on its sale to Luxium Solutions, a portfolio company of SK Capital Partners and Edgewater Capital Partners. This transaction marks Luxium's first acquisition since its 2022 investment by the private equity firms and aims to broaden Luxium's photonics assembly solutions with PLX's optical engineering capabilities.New Jersey Business MagazineInrad to Be Acquired by Luxium for $19MInrad Optics has entered into a definitive merger agreement to be acquired by Luxium Solutions for $19 million in an all-cash transaction. The acquisition, led by private equity firms SK Capital Partners and Edgewater Capital Partners, is expected to close in mid-2024, allowing Inrad to accelerate investments in next-generation optical technologies under new ownership.PR NewswireAmeriWater, a Portfolio Company of Edgewater Capital Partners, Announces Mark Doolittle as SVP, Sales and MarketingAmeriWater, an industry leader in water purification systems for dialysis, healthcare, and industrial applications, announced Mark Doolittle as its new Senior Vice President of Sales and Marketing. Doolittle brings extensive experience from senior commercial roles at Covalon Technologies and other medical device companies, with expertise in team development, strategic account management, and regulated medical device environments. The appointment supports AmeriWater's stated strategy to scale operations and expand its diversified water purification business.